# Is the somatic dimension of the HBSC-SCL predictive of psychiatric endpoints and vice-versa
(ie is there a "psychiatric" MHC and a "somatic" MHC)

If strongly so, it indicates that MHC captures mostly early symptoms of what we categorise as psychiatric disorders.

This is supported by Gobina 2015.

When I say endpoints, I mean medication use and hospital contacts. If it is associated in non-face-valid ways, that indicates that it may have incremental validity. But a better way is to use [[Rejected: Does MHC have direct effects on medication use]].

## Backlinks
* [[Is MHC associated with outcomes in ways that are not face valid]]
	* [[Is the somatic dimension of the HBSC-SCL predictive of psychiatric endpoints and vice-versa]]
* [[Â§Towards an understanding of Multiple Health Complaints]]
	* [[Is the somatic dimension of the HBSC-SCL predictive of psychiatric endpoints and vice-versa]]

<!-- #Work -->

<!-- {BearID:E4DD9E8A-D4D6-46D3-BBA4-E1BB3D5594D7-15756-0000130BCC42E3CA} -->
